Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This clinical trial involves the administration of the chemotherapeutic medication
vinflunine. Vinflunine is not approved by the FDA and is experimental in the treatment of
extensive small cell lung cancer. The purpose of this research trial is to study the
effectiveness of vinflunine in patients with relapsed extensive small cell lung cancer,
evaluate the toxicity, and evaluate how long the response to this drug lasts.